137 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34710708 | Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease. | 2022 Jan | 2 |
2 | 35101526 | COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. | 2022 May | 1 |
3 | 35173863 | Deciphering the involvement of iron targets in colorectal cancer: a network biology approach. | 2022 | 1 |
4 | 35192961 | Comorbidity of osteoporosis and Alzheimer's disease: Is `AKT `-ing on cellular glucose uptake the missing link? | 2022 Apr | 1 |
5 | 35404886 | The Role of Estrogen Signaling in Cellular Iron Metabolism in Pancreatic β Cells. | 2022 Feb 1 | 2 |
6 | 32479616 | Deferiprone Stimulates Aged Dermal Fibroblasts via HIF-1α Modulation. | 2021 Mar 12 | 1 |
7 | 33932034 | BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis. | 2021 May 17 | 1 |
8 | 33969609 | Lysosome Fe2+ release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells. | 2021 Aug | 1 |
9 | 34389031 | Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. | 2021 Aug 13 | 1 |
10 | 34714626 | Kinetic Studies of the Hydrogen Atom Transfer in a Hypoxia-Sensing Enzyme, FIH-1: KIE and O2 Reactivity. | 2021 Nov 9 | 2 |
11 | 31927949 | Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth. | 2020 Jan 28 | 1 |
12 | 32380365 | Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes. | 2020 Apr 25 | 5 |
13 | 32420530 | HIF1α-dependent mitophagy facilitates cardiomyoblast differentiation. | 2020 Mar 4 | 1 |
14 | 32477344 | Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis. | 2020 | 1 |
15 | 32541839 | Iron chelation inhibits mTORC1 signaling involving activation of AMPK and REDD1/Bnip3 pathways. | 2020 Jul | 1 |
16 | 32881223 | Ferric Ion Driven Assembly of Catalase-like Supramolecular Photosensitizing Nanozymes for Combating Hypoxic Tumors. | 2020 Dec 14 | 2 |
17 | 30553971 | Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation. | 2019 Mar | 1 |
18 | 31672495 | Relationships between hypoxia induced factor-1α and 18F-FDG PET/CT parameters in colorectal cancer. | 2019 Nov - Dec | 2 |
19 | 29318974 | Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities. | 2018 | 1 |
20 | 29580991 | Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH. | 2018 May 15 | 1 |
21 | 29764240 | Ferrous glycinate regulates cell energy metabolism by restrictinghypoxia-induced factor-1α expression in human A549 cells. | 2018 Dec | 2 |
22 | 30148961 | O2 Activation by Nonheme FeII α-Ketoglutarate-Dependent Enzyme Variants: Elucidating the Role of the Facial Triad Carboxylate in FIH. | 2018 Sep 19 | 1 |
23 | 27848940 | Parenteral iron polymaltose changes i:c-terminal FGF23 ratios in iron deficiency, but not in dialysis patients. | 2017 Feb | 1 |
24 | 28004401 | Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease. | 2017 Mar | 1 |
25 | 28296633 | The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1α prolyl hydroxylation by regulating cellular iron levels. | 2017 Mar 15 | 1 |
26 | 28460338 | Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome. | 2017 Jul | 9 |
27 | 26818499 | Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease. | 2016 Jan 27 | 4 |
28 | 27449336 | Local delivery of iron chelators reduces in vivo remodeling of a calcium phosphate bone graft substitute. | 2016 Sep 15 | 2 |
29 | 24803010 | Hypoxia-inducible factor-1α (HIF-1α) expression in placentae of women with iron deficiency anemia and β-thalassemia trait. | 2015 Mar | 1 |
30 | 25535360 | Transdermal deferoxamine prevents pressure-induced diabetic ulcers. | 2015 Jan 6 | 1 |
31 | 25727755 | Iron Regulatory Protein 1 Suppresses Hypoxia-Induced Iron Uptake Proteins Expression and Decreases Iron Levels in HepG2 Cells. | 2015 Sep | 1 |
32 | 24161166 | Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles. | 2014 Jan | 1 |
33 | 24397846 | Iron chelation and multiple sclerosis. | 2014 Jan 30 | 1 |
34 | 24495550 | Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response. | 2014 Apr | 2 |
35 | 24732598 | Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation. | 2014 | 2 |
36 | 25587028 | Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma. | 2014 Dec 30 | 1 |
37 | 22710383 | Hypoxia-inducible factor-1α (HIF-1α) potentiates β-cell survival after islet transplantation of human and mouse islets. | 2013 | 1 |
38 | 23097160 | Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. | 2013 Apr | 1 |
39 | 23160040 | Insulin promotes iron uptake in human hepatic cell by regulating transferrin receptor-1 transcription mediated by hypoxia inducible factor-1. | 2013 Feb | 3 |
40 | 23598047 | Deferoxamine expedites consolidation during mandibular distraction osteogenesis. | 2013 Aug | 1 |
41 | 23633457 | Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. | 2013 Jul 1 | 1 |
42 | 23640898 | Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin. | 2013 Jun 14 | 1 |
43 | 23709747 | Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells. | 2013 | 1 |
44 | 23787140 | Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change. | 2013 Sep | 1 |
45 | 24120591 | Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors. | 2013 Oct | 2 |
46 | 24211145 | Estrogen-dependent changes in serum iron levels as a translator of the adverse effects of estrogen during infection: a conceptual framework. | 2013 Dec | 2 |
47 | 21413014 | Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90. | 2012 Feb 1 | 1 |
48 | 22156453 | Novel therapeutic approach for neurodegenerative pathologies: multitarget iron-chelating drugs regulating hypoxia-inducible factor 1 signal transduction pathway. | 2012 | 3 |
49 | 22181812 | Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma. | 2012 Apr | 5 |
50 | 22198321 | Hypoxic preconditioning increases iron transport rate in astrocytes. | 2012 Apr | 6 |